D. Hallahan

发表

Imaging mass spectrometry: A new technology for the analysis of protein expression in mammalian tissues

M. Stoeckli, P. Chaurand, D. Hallahan, 2001, Nature Medicine.

Stress response genes induced in mammalian cells by ionizing radiation

D. Hallahan, R. Weichselbaum, D. Kufe, 1993 .

Characterization of Superparamagnetic Nanoparticle Interactions with Extracellular Matrix in an in Vitro System

Todd D. Giorgio, D. Hallahan, T. Giorgio, 2006, Annals of Biomedical Engineering.

TIP-1 Translocation onto the Cell Plasma Membrane Is a Molecular Biomarker of Tumor Response to Ionizing Radiation

D. Hallahan, Hailun Wang, Heping Yan, 2010, PloS one.

Noninvasive Cardiac Radiation for Ablation of Ventricular Tachycardia

D. Hallahan, Y. Rudy, S. Mutic, 2017, The New England journal of medicine.

Phantom validation of coregistration of PET and CT for image-guided radiotherapy.

B. Dawant, J. Fitzpatrick, D. Hallahan, 2004, Medical physics.

Measuring Tumor Perfusion in Control and Treated Murine Tumors

T. Yankeelov, D. Hallahan, A. Fleischer, 2007, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

A convenient, reliable, and fast acoustic pressure field measurement method for magnetic resonance-guided high-intensity focused ultrasound systems with phased array transducers

Satya V V N Kothapalli, Michael B Altman, Ari Partanen, 2018, Journal of therapeutic ultrasound.

A study on adaptive IMRT treatment planning using kV cone-beam CT.

D. Hallahan, M. Deeley, A. Cmelak, 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

GSK-3β: A Bifunctional Role in Cell Death Pathways

Sandeep R. Bhave, D. Hallahan, J. Jaboin, 2012, International journal of cell biology.

Combined modality therapy for tumor stage mycosis fungoides: results of a 10-year follow-up.

D. Hallahan, M. Griem, K. Soltani, 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

LABORATORY INVESTIGATION – HUMAN/ANIMAL TISSUE GSK-3b inhibition promotes cell death, apoptosis, and in vivo

D. Hallahan, S. Schleicher, Rong Hu, 2022 .

Ultrasound Hyperthermia Technology for Radiosensitization.

D. Hallahan, M. Altman, W. Straube, 2019, Ultrasound in medicine & biology.

Radiation induction of immediate early genes: effectors of the radiation-stress response.

D. Hallahan, R. Weichselbaum, D. Kufe, 1994, International journal of radiation oncology, biology, physics.

Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging.

Dean Billheimer, Christopher Scarfone, D. Hallahan, 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Linear release nanoparticle devices for advanced targeted cancer therapies with increased efficacy

D. Hallahan, E. Harth, V. Sathiyakumar, 2010 .

Correlation Between Estimates of Tumor Perfusion From Microbubble Contrast‐Enhanced Sonography and Dynamic Contrast‐Enhanced Magnetic Resonance Imaging

J. Gore, T. Yankeelov, D. Hallahan, 2006, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

Integrin αvβ3 antagonist Cilengitide enhances efficacy of radiotherapy in endothelial cell and non–small-cell lung cancer models

D. Hallahan, B. Lu, J. Albert, 2006 .

Cancer Therapy : Preclinical Anti-VEGF AntibodiesMitigate the Development of Radiation Necrosis in Mouse Brain

D. Hallahan, F. Gao, J. Engelbach, 2014 .

Reprogramming glioblastoma multiforme cells into neurons by protein kinase inhibitors

D. Hallahan, Ling-gang Wu, Qin Yang, 2018, Journal of Experimental & Clinical Cancer Research.

Exploiting Radiation Induction of Antigens in Cancer: Targeted Drug Delivery

D. Hallahan, Abhay K. Singh, S. Deore, 2022, International journal of molecular sciences.

p53 gene mutations and abnormal retinoblastoma protein in radiation-induced human sarcomas.

D. Brachman, D. Hallahan, R. Weichselbaum, 1991, Cancer research.

The world's first single-room proton therapy facility: Two-year experience.

D. Hallahan, J. Bradley, S. Mutic, 2016, Practical radiation oncology.

Association of 1p/19q Codeletion and Radiation Necrosis in Adult Cranial Gliomas After Proton or Photon Therapy.

D. Hallahan, J. Bradley, J. Michalski, 2018, International journal of radiation oncology, biology, physics.

Radiation induces an antitumour immune response to mouse melanoma

D. Hallahan, A. Fu, L. Geng, 2009, International journal of radiation biology.

Receptor tyrosine kinase inhibitors as anti-angiogenic agents.

D. Hallahan, B. Lu, D. W. Kim, 2004, Current opinion in investigational drugs.

Feasibility and safety assessment of magnetic resonance-guided high-intensity focused ultrasound (MRgHIFU)-mediated mild hyperthermia in pelvic targets evaluated using an in vivo porcine model

D. Hallahan, M. Altman, M. Talcott, 2019, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Protein kinase B/Akt-dependent phosphorylation of glycogen synthase kinase-3beta in irradiated vascular endothelium.

D. Hallahan, E. Yazlovitskaya, L. Geng, 2006, Cancer research.

Inhibition of αvβ3 Integrin Survival Signaling Enhances Antiangiogenic and Antitumor Effects of Radiotherapy

J. Debus, D. Hallahan, D. Griggs, 2005, Clinical Cancer Research.

Tumor microenvironment-targeted nanoparticles loaded with bortezomib and ROCK inhibitor improve efficacy in multiple myeloma

S. Achilefu, D. Hallahan, R. Vij, 2020, Nature Communications.

Noninvasive assessment of cancer response to therapy

D. Hallahan, Hailun Wang, A. Fu, 2008, Nature Medicine.

Molecular strategies targeting the host component of cancer to enhance tumor response to radiation therapy.

D. Hallahan, D. W. Kim, A. Fu, 2006, International journal of radiation oncology, biology, physics.

Mechanisms of X-ray-mediated protooncogene c-jun expression in radiation-induced human sarcoma cell lines.

D. Hallahan, R. Weichselbaum, D. Kufe, 1991, International journal of radiation oncology, biology, physics.

Eye shielding for patients treated with total body irradiation.

D. Hallahan, J. Roeske, C. Reft, 1996, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

Association of Posttreatment Lymphopenia and Elevated Neutrophil-to-Lymphocyte Ratio With Poor Clinical Outcomes in Patients With Human Papillomavirus-Negative Oropharyngeal Cancers.

D. Hallahan, R. Paniello, W. Thorstad, 2019, JAMA otolaryngology-- head & neck surgery.

Post-operative radiation effects on lymphopenia, neutrophil to lymphocyte ratio, and clinical outcomes in palatine tonsil cancers.

D. Hallahan, W. Thorstad, H. Gay, 2018, Oral oncology.

Histone deacetylase inhibitor NVP-LAQ824 sensitizes human nonsmall cell lung cancer to the cytotoxic effects of ionizing radiation

D. Hallahan, A. Fu, J. Huamani, 2007, Anti-cancer drugs.

Inflammation and Cell Adhesion Molecules are Involved in Radiation-Induced Lung Injury

D. Hallahan, C. Willey, 2008 .

Effects of intercellular adhesion molecule 1 (ICAM-1) null mutation on radiation-induced pulmonary fibrosis and respiratory insufficiency in mice.

D. Hallahan, Y. Shyr, L. Geng, 2002, Journal of the National Cancer Institute.

Impact of concurrent versus adjuvant chemotherapy on the severity and duration of lymphopenia in glioma patients treated with radiation therapy

D. Hallahan, Y. Rao, D. Thotala, 2017, Journal of Neuro-Oncology.

Akt is a major angiogenic mediator downstream of the Ang1/Tie2 signaling pathway.

D. Hallahan, L. Debusk, P. Lin, 2004, Experimental cell research.

Biological consequences of gene regulation after ionizing radiation exposure.

D. Hallahan, R. Weichselbaum, V. Sukhatme, 1991, Journal of the National Cancer Institute.

The patterns of failure in patients with pathological stage I and II diffuse histiocytic lymphoma treated with radiation therapy alone.

D. Hallahan, R. Weichselbaum, E. Vokes, 1989, International journal of radiation oncology, biology, physics.

Facile production of multivalent enzyme-nanoparticle conjugates

D. Hallahan, T. Giorgio, S. Kuhn, 2007 .

Nuclear survivin predicts recurrence and poor survival in patients with resected nonsmall cell lung carcinoma

D. Hallahan, P. Massion, D. Carbone, 2005, Cancer.

Radiation-Mediated Control of Drug Delivery

D. Hallahan, A. Cmelak, W. Martin, 2001, American journal of clinical oncology.

Cytosolic Phospholipase A2-Dependent Signaling Protects Normal Cells From Radiation-Induced Cytotoxicity

D. Hallahan, A. Linkous, E. Yazlovitskaya, 2007 .

Integrin alpha v beta 3 antagonist Cilengitide enhances efficacy of radiotherapy in endothelial cell and non-small-cell lung cancer models.

D. Hallahan, B. Lu, J. Albert, 2006, International journal of radiation oncology, biology, physics.

XIAP and survivin as therapeutic targets for radiation sensitization in preclinical models of lung cancer

D. Hallahan, B. Lu, Y. Mu, 2004, Oncogene.

P13.12: Microbubble contrast‐enhanced sonographic depiction of microvessel perfusion in an in vivo animal tumor model: implications for ovarian cancer

T. Yankeelov, D. Hallahan, A. Fleischer, 2004 .

Autophagy for Cancer Therapy through Inhibition of Pro-apoptotic Proteins and Mammalian Target of Rapamycin Signaling*

D. Hallahan, K. W. Kim, B. Lu, 2006, Journal of Biological Chemistry.

Radiation-guided drug delivery systems

D. Hallahan, B. Lu, D. Stacy, 2004, Expert review of anticancer therapy.

Targeting drug delivery to radiation-induced neoantigens in tumor microvasculature.

D. Hallahan, A. Cmelak, W. Martin, 2001, Journal of controlled release : official journal of the Controlled Release Society.

The Use of Antisense Oligonucleotides in Evaluating Survivin as a Therapeutic Target for Radiation Sensitization in Lung Cancer

D. Hallahan, B. Lu, E. Shinohara, 2004, Biological Procedures Online.

Survivin as a therapeutic target for radiation sensitization in lung cancer.

D. Hallahan, B. Lu, Jun Chen, 2004, Cancer Research.

Accumulation of P-selectin in the lumen of irradiated blood vessels.

D. Hallahan, S. Virudachalam, 1999, Radiation research.

Drug-radiation interactions in tumor blood vessels.

D. Hallahan, A. Cmelak, A. Y. Chen, 1999, Oncology.

Ketoconazole attenuates radiation-induction of tumor necrosis factor.

D. Hallahan, R. Weichselbaum, D. Kufe, 1994, International journal of radiation oncology, biology, physics.

GENE INDUCTION BY IONIZING RADIATION

D. Hallahan, R. Weichselbaum, D. Kufe, 1992 .

NDRG4, the N-Myc downstream regulated gene, is important for cell survival, tumor invasion and angiogenesis in meningiomas.

D. Hallahan, J. Jaboin, R. Vanderwaal, 2012, Integrative biology : quantitative biosciences from nano to macro.

Modifications of the fiber in adenovirus vectors increase tropism for malignant glioma models

D. Hallahan, I. Kovesdi, T. Wickham, 2000, Cancer Gene Therapy.

Hedgehog signaling in the murine melanoma microenvironment

D. Hallahan, A. Fu, M. K. Cooper, 2007, Angiogenesis.

Phosphatidylinositol 3-Kinase / Akt Signaling in the Response of Vascular Endothelium to Ionizing Radiation 1

D. Hallahan, L. Geng, E. Donnelly, 2002 .

HIV protease inhibitors enhance the efficacy of irradiation.

D. Hallahan, C. Willey, A. Fu, 2007, Cancer research.

PERK Regulates Glioblastoma Sensitivity to ER Stress Although Promoting Radiation Resistance

D. Hallahan, D. Thotala, D. Dadey, 2018, Molecular Cancer Research.

Myocardial Performance After EP-Guided Noninvasive Cardiac Radioablation (ENCORE) for Ventricular Tachycardia (VT)

D. Hallahan, S. Mutic, C. Robinson, 2017 .

Activation of NFκB and MnSOD gene expression by free radical scavengers in human microvascular endothelial cells

D. Hallahan, Y. Kataoka, J. Murley, 2001 .

The proteasome: a molecular target for cancer therapy.

D. Hallahan, M. Teng, 2000, International journal of radiation oncology, biology, physics.

A Specific Antagonist of the p110δ Catalytic Component of Phosphatidylinositol 3′-Kinase, IC486068, Enhances Radiation-Induced Tumor Vascular Destruction

D. Hallahan, K. Niermann, A. Fu, 2004, Cancer Research.

Radiation-Induced Tumor Vascular Destruction-Kinase , IC 486068 , Enhances ′ Phosphatidylinositol 3 Catalytic Component of δ A Specific Antagonist of the p 110 Updated

D. Hallahan, A. Fu, K. Cuneo, 2004 .

The ATF6 pathway of the ER stress response contributes to enhanced viability in glioblastoma

D. Hallahan, F. Urano, D. Thotala, 2015, Oncotarget.

Nuclear survivin as a biomarker for non-small-cell lung cancer

D. Hallahan, P. Massion, D. Carbone, 2004, British Journal of Cancer.

Improving cancer drug bioavailability by use of controlled delivery and release

D. Hallahan, 2015 .

Tumor necrosis factor alpha (TNF-alpha) gene therapy targeted by ionizing radiation selectively damages tumor vasculature.

D. Hallahan, R. Weichselbaum, J. Wayne, 1996, Cancer research.

Nuclear Factor icB Dominant Negative Genetic Constructs Inhibit X-ray Induction of Cell Adhesion Molecules in the Vascular Endothelium 1

D. Hallahan, S. Virudachalam, J. Kuchibhotla, 2006 .

Ionizing Radiation-Mediated Protein Kinase C Activation and Gene Expression

D. Hallahan, R. Weichselbaum, D. Kufe, 1991 .

SU 11248 Maintenance Therapy Prevents Tumor Regrowth after Fractionated Irradiation of Murine Tumor Models 1

D. Hallahan, G. Mcmahon, D. Mendel, 2003 .

Longer Term Results from a Phase I/II Study of EP-guided Noninvasive Cardiac Radioablation for Treatment of Ventricular Tachycardia (ENCORE-VT)

Geoffrey D. Hugo, D. Hallahan, R. Gropler, 2019, International Journal of Radiation Oncology*Biology*Physics.

E-selectin gene induction by ionizing radiation is independent of cytokine induction.

D. Hallahan, B. Gewertz, E. T. Clark, 1995, Biochemical and biophysical research communications.

Cardiac metastases from soft-tissue sarcomas.

D. Bostwick, D. Hallahan, K. Borow, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cellular and molecular mechanisms of radioresistance.

D. Brachman, D. Hallahan, R. Weichselbaum, 1995, Cancer treatment and research.

Tumor size does not limit radiation-inducible gene therapy in a human xenograft model

D. Hallahan, R. Weichselbaum, V. Sukhatme, 1995 .

The isoquinoline sulfonamide H7 attenuates radiation-mediated protein kinase C activation and delays the onset of x-ray-induced G2 arrest.

D. Hallahan, R. Weichselbaum, S. Virudachalam, 1992, International journal of radiation oncology, biology, physics.

Nuclear factor kappaB dominant negative genetic constructs inhibit X-ray induction of cell adhesion molecules in the vascular endothelium.

D. Hallahan, S. Virudachalam, J. Kuchibhotla, 1998, Cancer research.

Using in vivo biopanning for the development of radiation-guided drug delivery systems.

D. Hallahan, J. Jaboin, Z. Han, 2009, Methods in molecular biology.

A GSK-3β inhibitor protects against radiation necrosis in mouse brain.

D. Hallahan, F. Gao, J. Engelbach, 2014, International journal of radiation oncology, biology, physics.

Cytosolic PhospholipaseA2 Inhibition with PLA-695 Radiosensitizes Tumors in Lung Cancer Animal Models

D. Hallahan, J. Jaboin, D. Thotala, 2013, PloS one.

Lithium-mediated protection of hippocampal cells involves enhancement of DNA-PK-dependent repair in mice.

D. Hallahan, E. Yang, G. Jiang, 2009, The Journal of clinical investigation.

SRC family kinase inhibitor SU6656 enhances antiangiogenic effect of irradiation.

D. Hallahan, Y. Shyr, A. Fu, 2006, International journal of radiation oncology, biology, physics.

Enhancement of replication of genetically engineered herpes simplex viruses by ionizing radiation: a new paradigm for destruction of therapeutically intractable tumors

D. Hallahan, S. Advani, B. Roizman, 1998, Gene Therapy.

Tumor-Specific Binding of Radiolabeled PEGylated GIRLRG Peptide: A Novel Agent for Targeting Cancers

D. Hallahan, S. Wildman, B. Rogers, 2016, The Journal of Nuclear Medicine.

Integrin-mediated targeting of drug delivery to irradiated tumor blood vessels.

Christopher Scarfone, Todd Giorgio, D. Hallahan, 2003, Cancer cell.

High-throughput identification of putative receptors for cancer-binding peptides using biopanning and microarray analysis.

D. Hallahan, J. Jaboin, S. Wildman, 2013, Integrative biology : quantitative biosciences from nano to macro.

Pyridoxamine protects intestinal epithelium from ionizing radiation-induced apoptosis.

D. Hallahan, E. Yazlovitskaya, B. Hudson, 2009, Free radical biology & medicine.

High dose chemotherapy and stem cell rescue for aggressive non-Hodgkin's lymphoma: pattern of failure and implications for involved-field radiotherapy.

D. Hallahan, A. Mundt, S. Williams, 1997, International journal of radiation oncology, biology, physics.

Autotaxin and LPA Receptors Represent Potential Molecular Targets for the Radiosensitization of Murine Glioma through Effects on Tumor Vasculature

D. Hallahan, A. Linkous, E. Yazlovitskaya, 2011, PloS one.

Inhibition of alpha(v)beta3 integrin survival signaling enhances antiangiogenic and antitumor effects of radiotherapy.

J. Debus, D. Hallahan, D. Griggs, 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

Membrane-derived second messenger regulates x-ray-mediated tumor necrosis factor alpha gene induction.

D. Hallahan, R. Weichselbaum, D. Kufe, 1994, Proceedings of the National Academy of Sciences of the United States of America.

PEGylated peptide to TIP1 is a novel targeting agent that binds specifically to various cancers in vivo

D. Hallahan, B. Rogers, D. Thotala, 2019, Journal of controlled release : official journal of the Controlled Release Society.

SU‐FF‐J‐18: Adaptive IMRT Using Cone‐Beam CT: A Case Study On Patients with Bulky Head and Neck Tumors

D. Hallahan, M. Deeley, G. Ding, 2006 .

Unique epigenetic influence of H2AX phosphorylation and H3K56 acetylation on normal stem cell radioresponses

D. Hallahan, S. Misri, B. Sleckman, 2016, Molecular biology of the cell.

TNF-alpha and IL-1 upregulate membrane-bound and soluble E-selectin through a common pathway.

D. Hallahan, B. Gewertz, J. Kuchibhotla, 1997, The Journal of surgical research.

ATM Inhibition Sensitizes Tumors to High-Dose Irradiation.

D. Hallahan, 2019, Cancer research.

Radiation induces iatrogenic immunosuppression by indirectly affecting hematopoiesis in bone marrow

D. Hallahan, Xiaowei Wang, D. Link, 2020, Oncotarget.

Checkpoint kinase 2-mediated phosphorylation of BRCA1 regulates the fidelity of nonhomologous end-joining.

D. Hallahan, Hong Wang, S. Powell, 2006, Cancer research.

DNA-dependent protein kinase is a molecular target for the development of noncytotoxic radiation-sensitizing drugs.

D. Hallahan, Heidi Chen, L. Geng, 2005, Cancer research.

DNA-Dependent Protein Kinase Is a Molecular Target for the Development of Noncytotoxic Radiation–Sensitizing Drugs

D. Hallahan, Heidi Chen, L. Geng, 2005 .

Bone marrow X kinase-mediated signal transduction in irradiated vascular endothelium.

D. Hallahan, C. Willey, D. Thotala, 2008, Cancer research.

Growth factor-independent activation of protein kinase B contributes to the inherent resistance of vascular endothelium to radiation-induced apoptotic response.

D. Hallahan, Jiahuai Tan, 2003, Cancer research.

A dose escalation study of total body irradiation followed by high-dose etoposide and allogeneic blood stem cell transplantation for the treatment of advanced hematologic malignancies

D. Hallahan, R. Larson, G. Laport, 2000, Bone Marrow Transplantation.

p53 and p21 Are Major Cellular Determinants for DNA Topoisomerase I‐Mediated Radiation Sensitization in Mammalian Cells

D. Hallahan, M. Rothenberg, P. Scruggs, 2000, Annals of the New York Academy of Sciences.

Two prostate carcinoma cell lines demonstrate abnormalities in tumor suppressor genes.

D. Brachman, D. Hallahan, R. Weichselbaum, 1991, Journal of surgical oncology.

A Molecular Imaging Paradigm to Rapidly Profile Response to Angiogenesis-directed Therapy in Small Animals

John C. Gore, Carlos L. Arteaga, Jingping Xie, 2009, Molecular Imaging and Biology.

Virally directed cytosine deaminase/5-fluorocytosine gene therapy enhances radiation response in human cancer xenografts.

D. Hallahan, R. Weichselbaum, J. Wayne, 1997, Cancer research.

Involvement of reactive oxygen intermediates in the induction of c-jun gene transcription by ionizing radiation.

D. Hallahan, R. Weichselbaum, D. Kufe, 1992, Biochemistry.

Gene therapy targeted by radiation preferentially radiosensitizes tumor cells.

D. Hallahan, R. Weichselbaum, V. Sukhatme, 1994, Cancer research.

Tumor necrosis factor α (TNF-α) gene therapy targeted by ionizing radiation selectively damages tumor vasculature

D. Hallahan, R. Weichselbaum, J. Wayne, 1996 .

Spatial and temporal control of gene therapy using ionizing radiation

Samuel Hellman, Ralph R. Weichselbaum, D. Hallahan, 1995, Nature Medicine.

Increased tumor necrosis factor alpha mRNA after cellular exposure to ionizing radiation.

D. Hallahan, R. Weichselbaum, D. Kufe, 1989, Proceedings of the National Academy of Sciences of the United States of America.

The Use of Gene Therapy in Cancer Research and Treatment

D. Hallahan, B. Lu, E. Shinohara, 2004, Technology in cancer research & treatment.

Molecular and epigenetic regulatory mechanisms of normal stem cell radiosensitivity

D. Hallahan, Maria Rita Fabbrizi, G. Sharma, 2018, Cell Death Discovery.

Anti-tax interacting protein-1 (TIP-1) monoclonal antibody targets human cancers

D. Hallahan, R. Laforest, Heping Yan, 2016, Oncotarget.

Tax-interacting protein 1 coordinates the spatiotemporal activation of Rho GTPases and regulates the infiltrative growth of human glioblastoma

D. Hallahan, J. Rich, W. Whetsell, 2013, Oncogene.

Inhibition of vascular endothelial growth factor receptor signaling leads to reversal of tumor resistance to radiotherapy.

D. Hallahan, G. Mcmahon, P. Lin, 2001, Cancer research.

Valproic acid enhances the efficacy of radiation therapy by protecting normal hippocampal neurons and sensitizing malignant glioblastoma cells

D. Hallahan, J. Engelbach, A. Hallahan, 2015, Oncotarget.

Radiation-induced circulating myeloid-derived suppressor cells induce systemic lymphopenia after chemoradiotherapy in patients with glioblastoma

D. Hallahan, Xiaowei Wang, Subhajit Ghosh, 2023, Science Translational Medicine.

Effect of Radiation Treatment Volume Reduction on Lymphopenia in Patients Receiving Chemoradiotherapy for Glioblastoma.

D. Hallahan, C. Tsien, Deshan Yang, 2018, International journal of radiation oncology, biology, physics.

Stem Cell Transfusion Restores Immune Function in Radiation-Induced Lymphopenic C57BL/6 Mice.

D. Hallahan, A. Azab, D. Thotala, 2015, Cancer research.

RETRACTED ARTICLE: Reprogramming glioblastoma multiforme cells into neurons by protein kinase inhibitors

D. Hallahan, Qin Yang, Liming He, 2018, Journal of Experimental & Clinical Cancer Research.

Role of gene therapy in radiation oncology.

D. Hallahan, R. Weichselbaum, 1998, Cancer treatment and research.

Ionizing radiation regulates expression of the c-jun protooncogene.

D. Hallahan, R. Weichselbaum, D. Kufe, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Ionizing radiation activates transcription of the EGR1 gene via CArG elements.

D. Hallahan, R. Weichselbaum, V. Sukhatme, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Protein kinase C mediates x-ray inducibility of nuclear signal transducers EGR1 and JUN.

D. Hallahan, R. Weichselbaum, V. Sukhatme, 1991, Proceedings of the National Academy of Sciences of the United States of America.

Regulation of tumor necrosis factor gene expression by ionizing radiation in human myeloid leukemia cells and peripheral blood monocytes.

D. Hallahan, R. Weichselbaum, D. Kufe, 1991, The Journal of clinical investigation.

Intercellular adhesion molecule 1 knockout abrogates radiation induced pulmonary inflammation.

D. Hallahan, S. Virudachalam, Dennis E. Hallahan, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Cell adhesion molecules mediate radiation-induced leukocyte adhesion to the vascular endothelium.

D. Hallahan, J. Kuchibhotla, C. Wyble, 1996, Cancer research.

c-jun and Egr-1 Participate in DNA Synthesis and Cell Survival in Response to Ionizing Radiation Exposure (*)

D. Hallahan, R. Weichselbaum, V. Sukhatme, 1995, The Journal of Biological Chemistry.

The role of cytokines in radiation oncology.

D. Hallahan, R. Weichselbaum, D. Kufe, 1993, Important advances in oncology.

Retargeted adenoviruses for radiation-guided gene delivery

D. Hallahan, V. Kapoor, S. Kaliberov, 2016, Cancer Gene Therapy.

Tumor-targeted delivery of liposome-encapsulated doxorubicin by use of a peptide that selectively binds to irradiated tumors.

D. Hallahan, Amanda R. Lowery, H. Onishko, 2011, Journal of controlled release : official journal of the Controlled Release Society.

Multifunctional FePt Nanoparticles for Radiation-Guided Targeting and Imaging of Cancer

Matthew S. Wellons, Charles M. Lukehart, D. Hallahan, 2011, Annals of Biomedical Engineering.

Radiation-Guided Drug Delivery to Mouse Models of Lung Cancer

D. Hallahan, Hailun Wang, Heping Yan, 2010, Clinical Cancer Research.

Murine double minute 2 as a therapeutic target for radiation sensitization of lung cancer

D. Hallahan, E. Donnelly, K. Niermann, 2005, Molecular Cancer Therapeutics.

A new class of molecular targeted radioprotectors: GSK-3beta inhibitors.

D. Hallahan, E. Yazlovitskaya, D. Thotala, 2010, International journal of radiation oncology, biology, physics.

STI571 (Gleevec) improves tumor growth delay and survival in irradiated mouse models of glioblastoma.

D. Hallahan, Y. Shyr, D. Kim, 2006, International journal of radiation oncology, biology, physics.

The receptor tyrosine kinase inhibitor SU11248 impedes endothelial cell migration, tubule formation, and blood vessel formation in vivo, but has little effect on existing tumor vessels

D. Hallahan, Y. Shyr, A. Fu, 2004, Angiogenesis.

The Use of Tyrosine Kinase Inhibitors in Modifying the Response of Tumor Microvasculature to Radiotherapy

D. Hallahan, B. Lu, L. Geng, 2005, Technology in cancer research & treatment.

Phosphatidylinositol 3-kinase/Akt signaling in the response of vascular endothelium to ionizing radiation.

D. Hallahan, L. Geng, E. Donnelly, 2002, Cancer research.

Silencing Egr1 Attenuates Radiation-Induced Apoptosis in Normal Tissues while Killing Cancer Cells and Delaying Tumor Growth

D. Hallahan, D. Thotala, Keith M. Jacobs, 2015, Molecular Cancer Therapeutics.

Lithium treatment prevents neurocognitive deficit resulting from cranial irradiation.

D. Hallahan, B. Boone, E. Yazlovitskaya, 2006, Cancer research.

SU11248 (sunitinib) sensitizes pancreatic cancer to the cytotoxic effects of ionizing radiation.

D. Hallahan, A. Chakravarthy, A. Fu, 2007, International journal of radiation oncology, biology, physics.

Histone deacetylase (HDAC) inhibitor LBH589 increases duration of gamma-H2AX foci and confines HDAC4 to the cytoplasm in irradiated non-small cell lung cancer.

D. Hallahan, P. Atadja, A. Fu, 2006, Cancer research.

SU11248 maintenance therapy prevents tumor regrowth after fractionated irradiation of murine tumor models.

Gerald McMahon, D. Hallahan, G. Mcmahon, 2003, Cancer research.

An NAD+-dependent transcriptional program governs self-renewal and radiation resistance in glioblastoma

D. Hallahan, J. Milbrandt, D. Tran, 2016, Proceedings of the National Academy of Sciences.

TAF15 contributes to the radiation-inducible stress response in cancer

D. Hallahan, D. Thotala, V. Kapoor, 2020, Oncotarget.

Mycosis fungoides involving the central nervous system.

D. Hallahan, M. Griem, J. Baron, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Membrane phospholipids, EML4-ALK, and Hsp90 as novel targets in lung cancer treatment.

D. Hallahan, A. Laszlo, D. Thotala, 2013, Cancer journal.

High-energy total body irradiation as preparation for bone marrow transplantation in leukemia patients: treatment technique and related complications.

D. Hallahan, J. Bradley, C. Reft, 1998, International journal of radiation oncology, biology, physics.

Ionizing radiation mediates expression of cell adhesion molecules in distinct histological patterns within the lung.

D. Hallahan, S. Virudachalam, 1997, Cancer research.

Patterns of failure following total body irradiation and bone marrow transplantation with or without a radiotherapy boost for advanced neuroblastoma.

D. Hallahan, R. Weichselbaum, A. Mundt, 1995, International journal of radiation oncology, biology, physics.

Transient PP2A inhibition alleviates normal tissue stem cell susceptibility to cell death during radiotherapy

D. Hallahan, S. Misri, Maria Rita Fabbrizi, 2018, Cell Death & Disease.

Targeted nanoparticles that deliver a sustained, specific release of Paclitaxel to irradiated tumors.

Eva Harth, Hongmei Wu, Daniel E Spratt, 2010, Cancer research.

Radiosensitization of lung cancer by nutlin, an inhibitor of murine double minute 2

D. Hallahan, B. Lu, J. Albert, 2006, Molecular Cancer Therapeutics.

Prolonged c-jun expression in irradiated ataxia telangiectasia fibroblasts.

D. Hallahan, R. Weichselbaum, A. Kraft, 1996, International journal of radiation oncology, biology, physics.

The interaction between recombinant human tumor necrosis factor and radiation in 13 human tumor cell lines.

D. Hallahan, R. Weichselbaum, D. Kufe, 1990, International journal of radiation oncology, biology, physics.

Tumor necrosis factor gene expression is mediated by protein kinase C following activation by ionizing radiation.

D. Hallahan, R. Weichselbaum, D. Kufe, 1991, Cancer research.

Kinomic profiling approach identifies Trk as a novel radiation modulator.

D. Hallahan, J. Jaboin, E. Yang, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Histone H3 Lysine 9 Acetylation Obstructs ATM Activation and Promotes Ionizing Radiation Sensitivity in Normal Stem Cells

D. Hallahan, Maria Rita Fabbrizi, G. Sharma, 2016, Stem cell reports.

Towards novel radiosensitizing agents: the role of cytosolic PLA2α in combined modality cancer therapy.

D. Hallahan, Jeffrey Craft, 2011, Future medicinal chemistry.

Cytosolic Phospholipase A2 and Lysophospholipids in Tumor Angiogenesis

D. Hallahan, A. Linkous, E. Yazlovitskaya, 2010, Journal of the National Cancer Institute.

TNF-α and IL-1 Upregulate Membrane-Bound and Soluble E-Selectin through a Common Pathway

D. Hallahan, B. Gewertz, J. Kuchibhotla, 1997 .

Anti-VEGF Antibodies Mitigate the Development of Radiation Necrosis in Mouse Brain

D. Hallahan, F. Gao, J. Engelbach, 2014, Clinical Cancer Research.

Antibody Targeting GRP78 Enhances the Efficacy of Radiation Therapy in Human Glioblastoma and Non–Small Cell Lung Cancer Cell Lines and Tumor Models

D. Hallahan, D. Thotala, K. Hoye, 2016, Clinical Cancer Research.

Adenoviral TNF-α gene therapy and radiation damage tumor vasculature in a human malignant glioma xenograft

D. Hallahan, R. Weichselbaum, D. Kufe, 1998, Gene Therapy.

Enhanced radiation damage of tumor vasculature by mTOR inhibitors

D. Hallahan, K. Niermann, B. Lu, 2005, Oncogene.

Autotaxin Inhibition with PF-8380 Enhances the Radiosensitivity of Human and Murine Glioblastoma Cell Lines

D. Hallahan, J. Jaboin, A. Linkous, 2013, Front. Oncol..

Patterns of failure following high-dose chemotherapy and autologous bone marrow transplantation with involved field radiotherapy for relapsed/refractory Hodgkin's disease.

D. Hallahan, R. Weichselbaum, A. Mundt, 1995, International journal of radiation oncology, biology, physics.

Thoughts on the future of research, teaching, and testing in the biological sciences of radiation oncology.

D. Hallahan, M. Freeman, 2014, International journal of radiation oncology, biology, physics.

Genetic radiotherapy overcomes tumor resistance to cytotoxic agents.

D. Hallahan, R. Weichselbaum, M. Beckett, 1995, Cancer research.

Gene therapy targeted by ionizing radiation.

D. Hallahan, R. Weichselbaum, V. Sukhatme, 1992, International journal of radiation oncology, biology, physics.

Radiation therapy for pathologic stage III Hodgkin's disease with and without chemotherapy.

D. Hallahan, R. Weichselbaum, M. Griem, 1989, International journal of radiation oncology, biology, physics.

Radiation therapy for consolidation of metastatic or recurrent sarcomas in children treated with intensive chemotherapy and stem cell rescue. A feasibility study.

D. Hallahan, S. Goldman, J. Nachman, 1999, International journal of radiation oncology, biology, physics.

Sonographic Depiction of Changes of Tumor Vascularity in Response to Various Therapies

D. Hallahan, A. Fleischer, E. Donnelly, 2005, Ultrasound quarterly.

Quantification of Tumor Vascularity With Contrast‐Enhanced Sonography

D. Hallahan, A. Fleischer, E. Donnelly, 2004, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

Radiation signaling mediated by Jun activation following dissociation from a cell type-specific repressor.

D. Hallahan, R. Weichselbaum, V. Sukhatme, 1993, The Journal of biological chemistry.

Inhibition of protein kinases sensitizes human tumor cells to ionizing radiation.

D. Hallahan, R. Weichselbaum, J. Schwartz, 1992, Radiation research.

Two prostate carcinoma cell lines demonstrate abnormalities in tumor suppressor genes

D. Brachman, D. Hallahan, R. Weichselbaum, 1991, Journal of surgical oncology.

Radiation-Guided P-Selectin Antibody Targeted to Lung Cancer

D. Hallahan, M. Brechbiel, A. Fu, 2008, Annals of Biomedical Engineering.

Sialyl Lewis X mimetics attenuate E-selectin-mediated adhesion of leukocytes to irradiated human endothelial cells.

D. Hallahan, J. Kuchibhotla, C. Wyble, 1997, Radiation research.

Cytosolic Phospholipase A2 and Autotaxin Inhibitors as Potential Radiosensitizers

D. Hallahan, A. Laszlo, D. Thotala, 2014 .

The role of intracellular calcium in the cellular response to ionizing radiation.

D. Hallahan, R. Weichselbaum, D. Kufe, 1994, Radiation research.

Impact of inhomogeneity corrections on dose coverage in the treatment of lung cancer using stereotactic body radiation therapy.

D. Hallahan, M. Deeley, A. Cmelak, 2007, Medical physics.

Activation of NFkappaB and MnSOD gene expression by free radical scavengers in human microvascular endothelial cells.

D. Hallahan, J. C. Roberts, Y. Kataoka, 2001, Free radical biology & medicine.

Radiation-Guided Gene Therapy of Cancer

D. Hallahan, Hailun Wang, Zhaozhong Han, 2006, Technology in cancer research & treatment.

Phase I/II Trial of Electrophysiology-Guided Noninvasive Cardiac Radioablation for Ventricular Tachycardia

Geoffrey D. Hugo, D. Hallahan, R. Gropler, 2019, Circulation.

Breast conserving surgery and definitive irradiation for early stage breast cancer.

D. Hallahan, D. Spelbring, R. Weichselbaum, 1989, International journal of radiation oncology, biology, physics.

Deep-inspiration breath-hold kilovoltage cone-beam CT for setup of stereotactic body radiation therapy for lung tumors: initial experience.

Bo Lu, D. Hallahan, G. Ding, 2007, Lung cancer.

The Need for Accurate Dose Calculation Algorithms With Inhomogeneity Corrections in Treatment Planning for a Small Lung Tumor Treatment

D. Hallahan, A. Cmelak, G. Ding, 2007 .

Cytosolic Phospholipase A2: Targeting Cancer through the Tumor Vasculature

D. Hallahan, A. Lyshchik, A. Linkous, 2009, Clinical Cancer Research.

Advances in Brief Inhibition of Vascular Endothelial Growth Factor Receptor Signaling Leads to Reversal of Tumor Resistance to Radiotherapy 1

D. Hallahan, G. Mcmahon, P. Lin, 2001 .

Targeting a Radiosensitizing Antibody–Drug Conjugate to a Radiation-Inducible Antigen

D. Hallahan, F. Hsu, D. Thotala, 2021, Clinical Cancer Research.

Cytosolic phospholipase A2 as a molecular target for the radiosensitization of ovarian cancer.

D. Hallahan, A. Linkous, E. Yazlovitskaya, 2011, Cancer letters.

FDG PET in the follow-up management of patients with newly diagnosed Hodgkin and non-Hodgkin lymphoma after first-line chemotherapy.

Ronald R Price, D. Hallahan, R. Price, 2003, International journal of radiation oncology, biology, physics.

Increased expression of nuclear factor E2 p45‐related factor 2 (NRF2) in head and neck squamous cell carcinomas

D. Hallahan, P. Massion, W. Yarbrough, 2006, Head & neck.

Glycogen synthase kinase 3β inhibitors protect hippocampal neurons from radiation-induced apoptosis by regulating MDM2-p53 pathway

D. Hallahan, E. Yazlovitskaya, D. Thotala, 2011, Cell Death and Differentiation.

Inhibition of glycogen synthase kinase 3 beta attenuates neurocognitive dysfunction resulting from cranial irradiation.

D. Hallahan, E. Yazlovitskaya, D. Thotala, 2008, Cancer research.

Targetability of cervical cancer by magnetic resonance-guided high-intensity focused ultrasound (MRgHIFU)-mediated hyperthermia (HT) for patients receiving radiation therapy

P. Grigsby, D. Hallahan, M. Altman, 2021, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Characterization of magnetic resonance-guided high-intensity focused ultrasound (MRgHIFU)-induced large-volume hyperthermia in deep and superficial targets in a porcine model

D. Hallahan, M. Altman, M. Talcott, 2020, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Acoustic field characterization of a clinical magnetic resonance‐guided high‐intensity focused ultrasound system inside the magnet bore

Satya V. V. N. Kothapalli, D. Hallahan, M. Altman, 2017, Medical physics.

Sonographic Depiction of Microvessel Perfusion

T. Yankeelov, D. Hallahan, A. Fleischer, 2004, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

A Method for Assessing the Microvasculature in a Murine Tumor Model Using Contrast‐Enhanced Ultrasonography

Thomas E Yankeelov, John C Gore, Mary E Loveless, 2008, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

Molecular Imaging of Vascular Endothelial Growth Factor Receptor 2 Expression Using Targeted Contrast‐Enhanced High‐Frequency Ultrasonography

John C Gore, Marcela Brissova, Andrej Lyshchik, 2007, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

Evaluation and selection of anatomic sites for magnetic resonance imaging-guided mild hyperthermia therapy: a healthy volunteer study

D. Hallahan, M. Altman, H. Gach, 2018, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Recombinant Peptides as Biomarkers for Tumor Response to Molecular Targeted Therapy

D. Hallahan, Hongmei Wu, J. Phillips, 2009, Clinical Cancer Research.

Erratum: A specific antagonist of the p110δ catalytic component of phosphatidylinositol 3′-kinase, IC486068, enhances radiation-induced tumor vascular destruction (Cancer Research (July 2004) 64 (4893-4899)

D. Hallahan, K. Niermann, A. Fu, 2004 .

Molecular Targeted Drug Delivery Radiotherapy

D. Hallahan, E. Yazlovitskaya, 2011 .

Cytosolic phospholipase A2 regulates viability of irradiated vascular endothelium

D. Hallahan, A. Linkous, E. Yazlovitskaya, 2008, Cell Death and Differentiation.

Differential efficacy of combined therapy with radiation and AEE788 in high and low EGFR-expressing androgen-independent prostate tumor models.

Cameron C. Jones, Christopher Willey, Richard Caprioli, 2008, International journal of radiation oncology, biology, physics.

Determining glioma response to radiation therapy using recombinant peptides

D. Hallahan, R. Diaz, R. Passarella, 2008, Expert review of anticancer therapy.

X-irradiated vascular endothelium activates circulating blood components through exocytosis of membranous organelles containing preformed proteins

D. Hallahan, 1998 .

PDGFR-beta expression in small cell lung cancer patients.

D. Hallahan, P. Massion, D. Carbone, 2007, International journal of radiation oncology, biology, physics.

Concurrent chemo-radiotherapy with proton therapy: reduced toxicity with comparable oncological outcomes vs photon chemo-radiotherapy

D. Hallahan, J. Metz, J. Michalski, 2020, British Journal of Cancer.

Molecular and epigenetic regulatory mechanisms of normal stem cell radiosensitivity

D. Hallahan, Maria Rita Fabbrizi, G. Sharma, 2018, Cell Death Discovery.

Correlation of Quantified Contrast‐Enhanced Sonography With In Vivo Tumor Response

Andrej Lyshchik, Misun Hwang, D. Hallahan, 2010, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

Relationship Between Retention of a Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)‐Targeted Ultrasonographic Contrast Agent and the Level of VEGFR2 Expression in an In Vivo Breast Cancer Model

Andrej Lyshchik, D. Hallahan, A. Fleischer, 2008, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

Procedes et compositions de stimulation virale d'elimination de cellules

D. Hallahan, B. Roizman, G. Sibley, 1996 .

Cross-talk between ceramide and PKC activity in the control of apoptosis in WEHI-231.

D. Hallahan, R. Weichselbaum, S. Virudachalam, 1996, Advances in experimental medicine and biology.

XIAP and survivin as therapeutic targets for radiation sensitization in preclinical models of lung cancer

D. Hallahan, B. Lu, Y. Mu, 2004, Oncogene.

Phase I dose-escalation study of tumor necrosis factor-alpha and concomitant radiation therapy.

D. Hallahan, R. Weichselbaum, E. Vokes, 1995, The cancer journal from Scientific American.

Noninvasive Assessment of Tumor Vasculature Response to Radiation‐Mediated, Vasculature‐Targeted Therapy Using Quantified Power Doppler Sonography

Cameron C. Jones, T. Yankeelov, D. Hallahan, 2006, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

X-ray-induced P-selectin localization to the lumen of tumor blood vessels.

D. Hallahan, S. Virudachalam, A. Kolchinsky, 1998, Cancer research.

Proteolytic surface functionalization enhances in vitro magnetic nanoparticle mobility through extracellular matrix.

D. Hallahan, T. Giorgio, S. Kuhn, 2006, Nano letters.

Specificity of vascular endothelial growth factor treatment for radiation necrosis.

D. Hallahan, R. Schmidt, J. Ackerman, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A Gamma-Knife-Enabled Mouse Model of Cerebral Single-Hemisphere Delayed Radiation Necrosis

D. Hallahan, F. Gao, J. Engelbach, 2015, PloS one.

Radiation-guided drug delivery to tumor blood vessels results in improved tumor growth delay.

D. Hallahan, A. Fu, L. Geng, 2004, Journal of controlled release : official journal of the Controlled Release Society.

Quantified power Doppler US of tumor blood flow correlates with microscopic quantification of tumor blood vessels.

E F Donnelly, D. Hallahan, A. Fleischer, 2001, Radiology.